Department for Health and Social Care (DHSC) plasma announcement on the treatment of patients with TTP

Advice for our clinical colleagues following this announcement

Clinical colleagues should continue to follow BSH guidelines for the treatment of Thrombotic Thrombocytopenic Purpura, which advocate the use of solvent detergent plasma (SD-FFP) for this patient group.  

I would like to thank hospital colleagues for completing our survey capturing their initial response to the announcement. Nearly 50% of hospitals, currently being brought into our planning assumptions for the transition to UK plasma self-sufficiency responded to the survey. 

The survey is still available if you wish to take part.

We will provide updates on our implementation / rollout soon.

If you have any queries, please speak with your Customer Services Manager or Patient Blood Management Practitioner or email  

Alastair Hunter - Frozen Component Manager